Historical record - last NADAC effective date: 4/17/2024
Product Information
METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0858 per EA under NDC 43386057301. Its NADAC has been published 427 times since Mar 9, 2016.
FDA first approved this application on Nov 13, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386057301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207884FDA Approved
11/13/2015
TE Code
AB
On Market Since
1/20/2016
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 427 times since Mar 9, 2016, and over the history we have for it it has declined 81.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0858 per EA |
|---|---|
| All-time high | $0.4758 (May 11, 2016) |
| All-time low | $0.0858 (Apr 17, 2024) |
| Median price | $0.1342 |
| Average price | $0.1985 |
| Largest weekly change | -36.3% (Jul 18, 2018) |
| Weeks tracked | 427 |
| Tracking since | Mar 9, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-19.2%
5Y
-28.3%
All
-81.1%
Last surveyed May 8, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0858 per EA (NDC 43386057301), effective May 8, 2024.
How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has declined 81.1%. It has been tracked across 427 weekly CMS publications since Mar 9, 2016.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?
Since Mar 9, 2016, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0858 (Apr 17, 2024) to a high of $0.4758 (May 11, 2016), with a median of $0.1342 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 5 MG TABLET?
METHYLPHENIDATE 5 MG TABLET (NDC 43386057301) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.